iifl-logo

ICICI Pru Nifty Pharma Index Fund Dir IDCW

ICICI Pru Nifty Pharma Index Fund Dir IDCW

Fund Name

:  ICICI Prudential Mutual Fund

Scheme Name

:  ICICI Pru Nifty Pharma Index Fund Dir IDCW

AMC

:  ICICI Prudential Mutual Fund

Type

:  Open

Category

:  Equity - Index

Launch Date

:  25-Nov-2022

Fund Manager

:  Nishit Patel

Net Assets (Rs. cr)

:  156.88

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

ICICI Pru Nifty Pharma Index Fund Dir IDCW - Nav Details

Nav Date

:  08-Oct-2026

NAV [Rs.]

:  19.9955

Buy/Resale Price [Rs.]

:  0

Sell/Repurchase Price [Rs.]

:  0

Entry Load %

:  Nil

Exit Load %

:  Nil

ICICI Pru Nifty Pharma Index Fund Dir IDCW- NAV Chart

ICICI Pru Nifty Pharma Index Fund Dir IDCW- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-1.86
-3.95
1.63
17.55
19.09
19.51
-
19.89
Category Avg
-1.19
-6.56
-4.76
-0.68
-4.51
9.23
7.28
3.66
Category Best
3.14
7.79
8.19
33.61
36.39
34.16
18.33
25.37
Category Worst
-4.62
-11.82
-13.3
-17.87
-28.67
-4
3.3
-22.14

ICICI Pru Nifty Pharma Index Fund Dir IDCW- Latest Dividends

No Records Found

ICICI Pru Nifty Pharma Index Fund Dir IDCW- Investment Details

Min. Investment(Rs.)

:  1000

Increm.Investment(Rs.)

:  1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology19.5017508231.80
EquityDivi's Lab.Pharmaceuticals & Biotechnology11.972101319.52
EquityLaurus LabsPharmaceuticals & Biotechnology7.816440012.75
EquityCiplaPharmaceuticals & Biotechnology7.679305312.52
EquityDr Reddy's LabsPharmaceuticals & Biotechnology7.6210084212.43
EquityTorrent Pharma.Pharmaceuticals & Biotechnology7.162433211.67
EquityLupinPharmaceuticals & Biotechnology4.99401658.15
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.68456987.64
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology3.56248955.81
EquityAlkem LabPharmaceuticals & Biotechnology3.1599705.14
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.91409754.76
EquityMankind PharmaPharmaceuticals & Biotechnology2.87187374.69
EquityIpca Labs.Pharmaceuticals & Biotechnology2.71229714.42
EquityBioconPharmaceuticals & Biotechnology2.611152404.26
EquityGland PharmaPharmaceuticals & Biotechnology2.34131783.82
EquitySai LifePharmaceuticals & Biotechnology2.13228703.48
EquityWockhardtPharmaceuticals & Biotechnology1.77136592.89
EquityAjanta PharmaPharmaceuticals & Biotechnology1.6775372.72
EquityAbbott IndiaPharmaceuticals & Biotechnology1.438612.33
EquityPiramal PharmaPharmaceuticals & Biotechnology1.301027152.12

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
ICICI Prudential Mutual Fund
Incorporation Date:
22-Jun-1993
Total Assets Managed (Cr.):
12,20,480.62
Trustee/s:
Mr. Lakshman Kumar Mylava, ICICI Prudential Trust Lt
Chairman:
NA
CEO / MD:
Mr. Nimesh Shah
CIO:
NA
President:
NA
Director/s:
Mr. Nimesh Shah, Mr. Vijay Thacker, Ms. Vibha Paul Rishi, Ms.Anubhuti Sanghai, Ms.Preeti Reddy
Compliance Officer/s:
NA
Investor Service Officer/s:
Rajen Kotak
Fund Manager/s:
Nishit Patel
Auditors:
NA

OTHER INFORMATION

Registered Office:
One BKC, A-Wing, 13th Floor, Bandra Kurla Complex, Mumbai 400051
Contact Nos:
022 26525000
Fax:
022 26528100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.